( 0 1 0 1 O
aged 1 5 1 5 B-age
≥ 6 7 6 7 O
18 8 10 8 10 B-lower_bound
years 11 16 11 16 I-lower_bound
) 16 17 16 17 O

( 0 1 18 19 O
defined 1 8 19 26 O
as 9 11 27 29 O
an 12 14 30 32 O
average 15 22 33 40 O
of 23 25 41 43 O
≥2 26 28 44 46 O
units 29 34 47 52 I-lower_bound
of 35 37 53 55 O
RBC 38 41 56 59 B-treatment
transfusions 42 54 60 72 I-treatment
per 55 58 73 76 O
month 59 64 77 82 O
over 65 69 83 87 O
the 70 73 88 91 O
12 74 76 92 94 B-lower_bound
weeks 77 82 95 100 I-lower_bound
prior 83 88 101 106 I-lower_bound
to 89 91 107 109 O
enrollment 92 102 110 120 O
) 102 103 120 121 O

ANC 0 3 122 125 B-clinical_variable
≥ 4 5 126 127 O
1 6 7 128 129 B-lower_bound
x 8 9 130 131 I-lower_bound
10 10 12 132 134 I-lower_bound
^ 12 13 134 135 I-lower_bound
9 13 14 135 136 I-lower_bound
/ 14 15 136 137 I-lower_bound
L 15 16 137 138 I-lower_bound
without 17 24 139 146 O
the 25 28 147 150 O
assistance 29 39 151 161 O
of 40 42 162 164 O
granulocyte 43 54 165 176 B-treatment
growth 55 61 177 183 I-treatment
factors 62 69 184 191 I-treatment

Anemic 0 6 192 198 B-chronic_disease
, 6 7 198 199 O
defined 8 15 200 207 O
as 16 18 208 210 O
a 19 20 211 212 O
hemoglobin 21 31 213 223 B-clinical_variable
< 32 33 224 225 O
10g 34 37 226 229 B-upper_bound
/ 37 38 229 230 I-upper_bound
dL 38 40 230 232 I-upper_bound

At 0 2 233 235 O
least 3 8 236 241 O
2 9 10 242 243 B-lower_bound
symptoms 11 19 244 252 O
measurable 20 30 253 263 O
( 31 32 264 265 O
score 32 37 265 270 O
≥ 38 39 271 272 O
1 40 41 273 274 B-lower_bound
) 41 42 274 275 O
using 43 48 276 281 O
the 49 52 282 285 O
Myelofibrosis 53 66 286 299 B-clinical_variable
Symptom 67 74 300 307 I-clinical_variable
Assessment 75 85 308 318 I-clinical_variable
Form 86 90 319 323 I-clinical_variable
Version 91 98 324 331 I-clinical_variable
4.0 99 102 332 335 I-clinical_variable
( 103 104 336 337 I-clinical_variable
MFSAF 104 109 337 342 I-clinical_variable
v4.0 110 114 343 347 I-clinical_variable
) 114 115 347 348 I-clinical_variable

Current 0 7 349 356 O
known 8 13 357 362 O
active 14 20 363 369 O
or 21 23 370 372 O
chronic 24 31 373 380 B-chronic_disease
infection 32 41 381 390 I-chronic_disease
with 42 46 391 395 O
human 47 52 396 401 B-chronic_disease
immunodeficiency 53 69 402 418 I-chronic_disease
virus 70 75 419 424 I-chronic_disease
( 76 77 425 426 I-chronic_disease
HIV 77 80 426 429 I-chronic_disease
) 80 81 429 430 I-chronic_disease
, 81 82 430 431 O
Hepatitis 83 92 432 441 B-chronic_disease
B 93 94 442 443 I-chronic_disease
or 95 97 444 446 O
Hepatitis 98 107 447 456 B-chronic_disease
C 108 109 457 458 I-chronic_disease

Dynamic 0 7 459 466 B-clinical_variable
International 8 21 467 480 I-clinical_variable
Prognostic 22 32 481 491 I-clinical_variable
Scoring 33 40 492 499 I-clinical_variable
System 41 47 500 506 I-clinical_variable
( 48 49 507 508 O
DIPSS 49 54 508 513 O
; 54 55 513 514 O
see 56 59 515 518 O
Appendix 60 68 519 527 O
3 69 70 528 529 O
) 70 71 529 530 O
risk 72 76 531 535 O
category 77 85 536 544 O
of 86 88 545 547 O
intermediate-1 89 103 548 562 O
or 104 106 563 565 O
higher 107 113 566 572 O

ECOG 0 4 573 577 B-clinical_variable
performance 5 16 578 589 I-clinical_variable
status 17 23 590 596 I-clinical_variable
≤ 24 25 597 598 O
2 26 27 599 600 B-upper_bound

Impaired 0 8 601 609 O
cardiac 9 16 610 617 O
function 17 25 618 626 O
or 26 28 627 629 O
clinically 29 39 630 640 O
significant 40 51 641 652 O
cardiac 52 59 653 660 B-chronic_disease
diseases 60 68 661 669 I-chronic_disease

Impairment 0 10 670 680 B-chronic_disease
of 11 13 681 683 I-chronic_disease
gastrointestinal 14 30 684 700 I-chronic_disease
( 31 32 701 702 I-chronic_disease
GI 32 34 702 704 I-chronic_disease
) 34 35 704 705 I-chronic_disease
function 36 44 706 714 I-chronic_disease
or 45 47 715 717 O
GI 48 50 718 720 B-chronic_disease
disease 51 58 721 728 I-chronic_disease
that 59 63 729 733 O
could 64 69 734 739 O
significantly 70 83 740 753 O
alter 84 89 754 759 O
the 90 93 760 763 O
absorption 94 104 764 774 O
of 105 107 775 777 O
CPI-0610 108 116 778 786 B-treatment
and/or 117 123 787 793 O
ruxolitinib 124 135 794 805 B-treatment
, 135 136 805 806 O
including 137 146 807 816 O
any 147 150 817 820 O
unresolved 151 161 821 831 O
nausea 162 168 832 838 O
, 168 169 838 839 O
vomiting 170 178 840 848 O
, 178 179 848 849 O
or 180 182 850 852 O
diarrhea 183 191 853 861 B-chronic_disease
that 192 196 862 866 O
is 197 199 867 869 O
CTCAE 200 205 870 875 B-clinical_variable
grade 206 211 876 881 I-clinical_variable
> 212 213 882 883 O
1 213 214 883 884 O

Monotherapy 0 11 885 896 O
Arm 12 15 897 900 O
( 16 17 901 902 O
Arm 17 20 902 905 O
1 21 22 906 907 O
): 22 24 907 909 O
Previously 25 35 910 920 O
treated 36 43 921 928 O
with 44 48 929 933 O
a 49 50 934 935 O
JAK 51 54 936 939 B-treatment
inhibitor 55 64 940 949 I-treatment
and 65 68 950 953 O
be 69 71 954 956 O
intolerant 72 82 957 967 O
, 82 83 967 968 O
resistant 84 93 969 978 O
, 93 94 978 979 O
refractory 95 105 980 990 O
or 106 108 991 993 O
lost 109 113 994 998 O
response 114 122 999 1007 O
to 123 125 1008 1010 O
the 126 129 1011 1014 O
JAK 130 133 1015 1018 O
inhibitor 134 143 1019 1028 O

No 0 2 1029 1031 O
prior 3 8 1032 1037 B-treatment
treatment 9 18 1038 1047 I-treatment
with 19 23 1048 1052 I-treatment
JAKi 24 28 1053 1057 I-treatment
allowed 29 36 1058 1065 O

Palpable 0 8 1066 1074 B-clinical_variable
spleen 9 15 1075 1081 I-clinical_variable
≥ 16 17 1082 1083 O
5 18 19 1084 1085 B-lower_bound
cm 20 22 1086 1088 I-lower_bound
that 23 27 1089 1093 O
is 28 30 1094 1096 O
below 31 36 1097 1102 O
the 37 40 1103 1106 O
costal 41 47 1107 1113 O
margin 48 54 1114 1120 O
on 55 57 1121 1123 O
physical 58 66 1124 1132 O
examination 67 78 1133 1144 O

Palpable 0 8 1145 1153 B-clinical_variable
spleen 9 15 1154 1160 I-clinical_variable
≥ 16 17 1161 1162 O
5 18 19 1163 1164 B-lower_bound
cm 20 22 1165 1167 I-lower_bound
that 23 27 1168 1172 O
is 28 30 1173 1175 O
below 31 36 1176 1181 O
the 37 40 1182 1185 O
costal 41 47 1186 1192 O
margin 48 54 1193 1199 O
on 55 57 1200 1202 O
physical 58 66 1203 1211 O
examination 67 78 1212 1223 O
OR 79 81 1224 1226 O
RBC 82 85 1227 1230 B-clinical_variable
transfusion 86 97 1231 1242 O
dependent 98 107 1243 1252 O

Patients 0 8 1253 1261 O
with 9 13 1262 1266 O
Child 14 19 1267 1272 B-clinical_variable
- 19 20 1272 1273 I-clinical_variable
Pugh 20 24 1273 1277 I-clinical_variable
Class 25 30 1278 1283 I-clinical_variable
B 31 32 1284 1285 I-clinical_variable
or 33 35 1286 1288 O
C 36 37 1289 1290 O

Patients 0 8 1291 1299 O
with 9 13 1300 1304 O
confirmed 14 23 1305 1314 O
diagnosis 24 33 1315 1324 O
of 34 36 1325 1327 O
MF 37 39 1328 1330 B-cancer

Peripheral 0 10 1331 1341 B-clinical_variable
blood 11 16 1342 1347 I-clinical_variable
blast 17 22 1348 1353 I-clinical_variable
count 23 28 1354 1359 I-clinical_variable
< 29 30 1360 1361 O
10 30 32 1361 1363 B-upper_bound
% 32 33 1363 1364 I-upper_bound

Platelet 0 8 1365 1373 B-clinical_variable
count 9 14 1374 1379 I-clinical_variable
≥ 15 16 1380 1381 O
100 17 20 1382 1385 B-lower_bound
x 21 22 1386 1387 I-lower_bound
10 23 25 1388 1390 I-lower_bound
^ 25 26 1390 1391 I-lower_bound
9 26 27 1391 1392 I-lower_bound
/ 27 28 1392 1393 I-lower_bound
L 28 29 1393 1394 I-lower_bound
without 30 37 1395 1402 O
the 38 41 1403 1406 O
assistance 42 52 1407 1417 O
of 53 55 1418 1420 O
thrombopoietic 56 70 1421 1435 O
factors 71 78 1436 1443 O
or 79 81 1444 1446 O
transfusions 82 94 1447 1459 O

Platelet 0 8 1460 1468 B-clinical_variable
count 9 14 1469 1474 I-clinical_variable
≥ 15 16 1475 1476 O
75 17 19 1477 1479 B-lower_bound
x 20 21 1480 1481 I-lower_bound
10 22 24 1482 1484 I-lower_bound
^ 24 25 1484 1485 I-lower_bound
9 25 26 1485 1486 I-lower_bound
/ 26 27 1486 1487 I-lower_bound
L 27 28 1487 1488 I-lower_bound
without 29 36 1489 1496 O
the 37 40 1497 1500 O
assistance 41 51 1501 1511 O
of 52 54 1512 1514 O
thrombopoietic 55 69 1515 1529 O
factors 70 77 1530 1537 O
or 78 80 1538 1540 O
transfusions 81 93 1541 1553 B-treatment
for 94 97 1554 1557 O
at 98 100 1558 1560 O
least 101 106 1561 1566 O
14 107 109 1567 1569 B-lower_bound
days 110 114 1570 1574 I-lower_bound

Pregnant 0 8 1575 1583 B-pregnancy
or 9 11 1584 1586 O
lactating 12 21 1587 1596 O
women 22 27 1597 1602 B-gender

Prior 0 5 1603 1608 B-treatment
treatment 6 15 1609 1618 I-treatment
with 16 20 1619 1623 I-treatment
a 21 22 1624 1625 I-treatment
BET 23 26 1626 1629 I-treatment
inhibitor 27 36 1630 1639 I-treatment

